文献速递血栓与止血

性别特异性DNA甲基化标记与无诱因静脉血栓栓塞症性别偏倚复发风险的关联

Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism.
PubMed 文献 · J Thromb Haemost · 2025-01-21

在417例无诱因静脉血栓栓塞症(VTE)患者(REVERSE I)中,采用Illumina EPIC阵列进行性别分层全表观基因组关联研究,并在181例主要诱因VTE患者(MARTHA)中进一步验证。男性TBC1D22B-cg01060850和ZHX2-cg07808424低甲基化、女性DIP2B-ch.12.1038646R和DENND3-cg03401656低甲基化与复发VTE在全基因组水平相关(P < 7x10-8)。作者认为DNA甲基化标记可能是无诱因VTE性别偏倚复发的潜在危险因素,需进一步复制和实验验证。

要点

  • 男性TBC1D22B-cg01060850和ZHX2-cg07808424低甲基化与复发VTE在全基因组水平相关(P < 7x10-8)。
  • 女性DIP2B-ch.12.1038646R和DENND3-cg03401656低甲基化与复发VTE在全基因组水平相关(P < 7x10-8)。
  • DENND3-cg03401656在MARTHA女性中效应方向相同但未达统计学显著。

核心结论

  • 研究识别出DNA甲基化标记可能是无诱因VTE性别偏倚复发的潜在危险因素。
  • 作者认为进一步复制和实验验证可完善对已识别DNA甲基化位点调控的理解,并帮助优化首次VTE后长期抗凝的个体化决策。

研究设计与样本

  • 在417例无诱因VTE患者(其中101例在5年随访期间复发,REVERSE I)中,使用Illumina EPIC阵列分析血液DNA甲基化,并进行性别分层全表观基因组关联研究。
  • 进一步在181例主要诱因VTE患者(其中36例在14年随访期间复发,MARTHA)中探究DNA甲基化是否为抗凝治疗后复发VTE的危险因素。

主要发现

  • 男性TBC1D22B-cg01060850和ZHX2-cg07808424低甲基化与复发VTE在全基因组水平相关(P < 7x10-8)。
  • 女性DIP2B-ch.12.1038646R和DENND3-cg03401656低甲基化与复发VTE在全基因组水平相关(P < 7x10-8)。
  • DENND3-cg03401656在MARTHA女性中效应方向相同,但未达统计学显著。
  • 敏感性分析证实了估计值的稳健性,包括潜在混杂因素、Cox模型的调整、非欧洲人群以及近端甲基化定量性状位点。
  • 相关CpG位于膜运输相关基因,佐证了Rab调节蛋白和转录因子参与复发VTE。

关键数值与推荐

  • 全基因组显著性阈值P < 7x10-8。
  • 男性复发VTE相关低甲基化位点:TBC1D22B-cg01060850、ZHX2-cg07808424。
  • 女性复发VTE相关低甲基化位点:DIP2B-ch.12.1038646R、DENND3-cg03401656。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要进一步复制和实验验证,以完善对已识别DNA甲基化位点调控的理解。
  • DENND3-cg03401656在MARTHA女性中效应方向相同但未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether to stop oral anticoagulants after a first unprovoked venous thromboembolism (VTE) is challenging, partially due to an intriguingly higher risk of VTE recurrence (rVTE) in men after therapy discontinuation. DNA methylation (DNAm) differences between men and women might underlie this sex-biased rVTE risk difference. OBJECTIVES: To investigate sex-specific associations between DNAm at cytosine-phosphate-guanine (CpG) sites and rVTE. METHODS: In 417 unprovoked VTE patients, including 101 experiencing recurrences over a 5-year follow-up (REcurrent VEnous thromboembolism Risk Stratification Evaluation [REVERSE] I), we analyzed blood DNAm using the Illumina EPIC array and performed a sex-stratified epigenome-wide association study. We further examined 181 major provoked VTE patients, including 36 recurrences over a 14-year follow-up (the MARseille THrombosis Association [MARTHA]), to investigate whether DNAm is a risk factor for rVTE after anticoagulation therapy. RESULTS: Hypomethylated CpGs at genes TBC1D22B-cg01060850 and ZHX2-cg07808424 in men and DIP2B-ch.12.1038646R and DENND3-cg03401656 in women were associated with rVTE at genome-wide level (P < 7x10-8). Though not statistically significant, DENND3-cg03401656 had the same direction of effect in MARTHA women. Sensitivity analysis confirmed the robustness of the estimates, including potential confounders, adaptations of the Cox model, non-Europeans, and proximal methylation quantitative trait loci in the association. The associated CpGs were situated at genes for membrane trafficking, corroborating the participation of Rab regulatory proteins in rVTE and transcription factors. CONCLUSION: We identified DNAm marks as potential risk factors for sex-biased recurrence in unprovoked VTE. Further replication and experimental validation could refine our understanding of the regulation of the identified DNAm sites and help optimize personalized decision-making for long-term anticoagulation after a first VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Bezerra OCL, Rodger M, Munsch G, et al. Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism. J Thromb Haemost. 2025. PMID: 39848545. doi:10.1016/j.jtha.2025.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。